| Market Capitalization (Millions $) |
65 |
| Shares
Outstanding (Millions) |
190 |
| Employees |
128 |
| Revenues (TTM) (Millions $) |
152 |
| Net Income (TTM) (Millions $) |
-34 |
| Cash Flow (TTM) (Millions $) |
10 |
| Capital Exp. (TTM) (Millions $) |
1 |
Business Description
Heron Therapeutics Inc. is a pharmaceutical company that is focused on the development and commercialization of innovative therapies to address unmet medical needs. The company is dedicated to providing patients with safe and effective alternatives to existing treatments that do not adequately address their conditions or that may be associated with undesirable side effects.
Heron Therapeutics was founded in 1983 and is based in San Diego, California. The company operates under the leadership of CEO Barry Quart, who has been with the company since 2000. The company has a team of over 300 employees who work tirelessly to develop new and innovative treatments that improve patient outcomes.
Heron Therapeutics has developed a proprietary drug delivery system called Sustained Release (SR) technology, which is used to develop long-acting formulations of existing drugs. The technology allows for drugs to be released over an extended period, which can eliminate the need for multiple dosing throughout the day. SR technology has been used to develop numerous products in the Heron pipeline, including Zynrelef (bupivacaine and meloxicam), a recently FDA-approved drug for postoperative pain management.
Heron Therapeutics focuses on developing products for pain management, cancer supportive care, and rare diseases. The company's lead product candidate, HTX-011, is a novel local anesthetic that is being developed for postoperative pain management. The drug, which is administered during surgery, has been shown to provide superior pain relief compared to existing therapies and may reduce the need for opioids to manage postoperative pain.
In addition to its research and development efforts, Heron Therapeutics has a focus on commercialization. The company has a dedicated sales and marketing team that is responsible for launching new products and promoting existing products to healthcare professionals.
Overall, Heron Therapeutics is a biotechnology company that is dedicated to advancing medical treatments for unmet medical needs. With a focus on innovation, research and development, and commercialization, the company is well-positioned for continued growth and success in the industry.
Company Address: 25 Fenton Main Street Cary 27511 NC
Company Phone Number: 251-4400 Stock Exchange / Ticker: NASDAQ HRTX
|
19.3% 
56.53 %